Kenza Health Hub logoGet Started
1 May 2026Oral drugsSource update: March 2024

Labetalol Oral: Dosing and Precautions

Labetalol guidance for hypertension in pregnancy, with beta-blocker precautions and neonatal monitoring advice.

Also searched as

Labetalol
Prescription under medical supervision

Source reviewed

March 2024

Guide category

Oral drugs

Safety boundary

Prescription medicine information for clinician-guided use.

Kenza Health Hub presents this medicine page as structured health education. Check dose, route, interactions, pregnancy or breast-feeding considerations, and local protocol with a qualified clinician or pharmacist. Read our medical editorial policy.

This guide page is for structured reference only and does not replace a clinician, pharmacist, or emergency review. Dose choice, route choice, interactions, and safety decisions still need professional judgment.

Therapeutic action

Non cardioselective beta-blocker.

Indications

Hypertension in pregnancy.

Forms and strengths

  • 100 mg and 200 mg tablets.

Dose

  • 100 mg 2 times daily.
  • Increase if necessary in 100 to 200 mg increments until an effective dose is reached, usually 400 to 800 mg daily, maximum 2400 mg daily.
  • If higher doses are required, give in 3 divided doses.

Duration

According to clinical response. Do not stop treatment abruptly; decrease doses gradually.

Contra-indications, adverse effects, precautions

  • Do not administer to patients with asthma, chronic obstructive bronchopneumonia, heart failure, severe hypotension, bradycardia under 50/minute, atrio-ventricular heart blocks, Raynaud's syndrome, or hepatic impairment.
  • May cause bradycardia, hypotension, heart failure, bronchospasm, hypoglycaemia, gastrointestinal disturbances, dizziness, headache, weakness, and urinary retention.
  • Administer with caution to patients with diabetes because of the risk of hypoglycaemia.
  • Reduce dosage in patients with renal impairment.
  • In the event of anaphylactic shock, there is a risk of resistance to epinephrine.
  • Avoid or monitor combination with mefloquine, digoxin, amiodarone, diltiazem, verapamil, tricyclic antidepressants, antipsychotics, and other antihypertensive drugs.
  • Do not administer simultaneously with antacids; administer 2 hours apart.
  • Monitor the neonate for hypoglycaemia, bradycardia, and respiratory distress during the first 24 to 72 hours after birth.
  • Breast-feeding: no contra-indication.

Source

MSF Essential drugs practical guidelines (January 2026)

This page combines source-derived medicine reference sections with Kenza editorial context, while leaving out the Storage and Remarks sections from the source batch.

Rate this guide

Be the first to rate this guide.